L. Rosenblatt

A. Nadkarni, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

J. Kremer, L. Harrold, H. Litman, 2017, Clinical Rheumatology.

Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer

A. Cohen, P. Hlavacek, Xuemei Luo, 2021, Current medical research and opinion.

Clinically Meaningful Improvements in Health-Related Quality of Lite, Pain and Sleep Quality in Children with Polyarticular Juvenile Idiopathic Arthritis Treated with Abatacept over the Long Term

A. Martini, P. Quartier, V. Gerloni, 2011 .

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis

A. Amin, O. Dina, L. Vo, 2022, Current medical research and opinion.

Outcomes and charges of elderly patients with acute myeloid leukemia

J. Doyle, M. Zilberberg, L. Stern, 2006, American journal of hematology.

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants

T. Ingall, C. Russ, G. Lip, 2022, JAMA network open.

Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS.

G. Ryan, D. Lowsky, D. Goldman, 2014, Health affairs.

Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid.

J. Romley, D. Goldman, T. Juday, 2014, Health affairs.

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice

S. Cole, R. Haubrich, A. Westfall, 2017, Medicine.

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

D. Sherris, E. Kern, L. Katz, 2007, Therapeutics and clinical risk management.

Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

A. Khorana, T. Bond, J. Barron, 2023, Journal for ImmunoTherapy of Cancer.

Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens

A. Villasis-Keever, E. Nkhoma, L. Rosenblatt, 2016, PloS one.

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

B. Meissner, L. Rosenblatt, D. Trivedi, 2014, Journal of medical economics.

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data

A. Farr, S. Johnston, A. Villasis-Keever, 2016, Medicine.

Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals

P. Tebas, J. LaFleur, A. Bress, 2018, Infectious Diseases and Therapy.

Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans Risk Modification by Concomitant Antiretrovirals

P. Tebas, J. LaFleur, A. Bress, 2017, Journal of acquired immune deficiency syndromes.

Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data

M. Broder, E. Chang, T. Bentley, 2015, AIDS care.

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

G. Lip, J. Mardekian, S. Deitelzweig, 2021, Advances in Therapy.

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

C. Russ, Jay Lin, S. Deitelzweig, 2020, Journal of medical economics.

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

C. Russ, O. Dina, Jay Lin, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

C. Russ, O. Dina, Jay Lin, 2019, Current medical research and opinion.

Effectiveness and Safety of Oral Anticoagulants Among Non-Valvular Atrial FibrillationPatients with Polypharmacy.

G. Lip, J. Mardekian, S. Deitelzweig, 2020, European heart journal. Cardiovascular pharmacotherapy.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population

J. Trocio, A. Nadkarni, O. Dina, 2018, Journal of managed care & specialty pharmacy.

Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study

G. Lip, G. Lip, X. Pan, 2020, Journal of internal medicine.

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

A. Cohen, P. Hlavacek, B. Emir, 2021, Journal of clinical medicine.

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens

A. Farr, S. Johnston, E. Nkhoma, 2016, Open forum infectious diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Changing Patterns of Tumor Necrosis Factor Inhibitor Use in 9074 Patients with Rheumatoid Arthritis

S. Krasnokutsky, Y. Yazici, Jason Wang, 2009, The Journal of Rheumatology.

Economic Outcomes of First-Line Regimen Switching Among Stable Patients with HIV.

A. Villasis-Keever, A. Buikema, L. Bengtson, 2017, Journal of managed care & specialty pharmacy.

Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

S. Sorensen, A. Tafazzoli, A. Villasis-Keever, 2015, Journal of medical economics.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomized clinical trial data.

G. Wu, C. Klem, Y. Yazici, 2011, Clinical and experimental rheumatology.

Proposed Severity and Response Criteria for Routine Assessment of Patient Index Data (RAPID3): Results for Categories of Disease Activity and Response Criteria in Abatacept Clinical Trials

T. Pincus, M. Bergman, R. Maclean, 2011, The Journal of Rheumatology.

Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.

Richard D Moore, M. Budoff, S. Heckbert, 2018, AIDS research and human retroviruses.

Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.

J. Newcomer, R. Baker, Edward Kim, 2009, The American journal of psychiatry.

Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the US.

Brian R Wood, Richard D Moore, M. Budoff, 2019, Journal of acquired immune deficiency syndromes.

The prospect of a generation free of HIV may be within reach if the right policy decisions are made.

D. Goldman, T. Juday, D. Seekins, 2014, Health affairs.

HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care.

N. Sood, J. Romley, D. Goldman, 2014, Health affairs.

Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.

Paul P. Lee, L. Siegartel, L. Stern, 2007, American journal of ophthalmology.

Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population

C. Russ, M. Ferri, P. Hlavacek, 2019, Current medical research and opinion.

Correction to: Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population

A. Amin, C. Russ, A. Nadkarni, 2019, Journal of Thrombosis and Thrombolysis.

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

G. Lip, A. Nadkarni, J. Mardekian, 2019, Journal of the American Geriatrics Society.

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population

A. Amin, C. Russ, A. Nadkarni, 2019, Journal of Thrombosis and Thrombolysis.

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

G. Lip, J. Mardekian, S. Deitelzweig, 2021, Therapeutic advances in gastroenterology.

Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry

J. Kremer, L. Harrold, H. Litman, 2018, The Journal of Rheumatology.

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

G. Lip, J. Mardekian, S. Deitelzweig, 2020, Journal of clinical medicine.

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

M. Hochberg, A. Nadkarni, S. Berry, 2013, Current medical research and opinion.

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

A. Cohen, P. Hlavacek, B. Emir, 2021, Advances in Therapy.

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States

C. Russ, O. Dina, Jay Lin, 2020, Journal of drug assessment.

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.

G. Lip, A. Nadkarni, J. Mardekian, 2020, Mayo Clinic proceedings.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.

C. Russ, M. Ferri, P. Hlavacek, 2020, Thrombosis research.

Original article Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

M. Hochberg, A. Nadkarni, S. Berry, 2013 .

Clinical characteristics, healthcare costs, and resource utilization in hepatitis C vary by genotype

C. Blauer-Peterson, C. Patel, L. Rosenblatt, 2017, Current medical research and opinion.

Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.

Lee Stern, J. Doyle, W. Lumry, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis

A. Cohen, P. Hlavacek, J. Mardekian, 2020, Thrombosis and Haemostasis.

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

A. Cohen, B. Emir, Xuemei Luo, 2023, Advances in Therapy.

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

S. Sorensen, Hong Tang, N. Tsai, 2012, ClinicoEconomics and outcomes research : CEOR.

Validation of obesity coding among newly treated nonvalvular atrial fibrillation patients using an integrated electronic medical record and claims database

J. Menzin, J. Mardekian, R. Jain, 2020, Current medical research and opinion.

Original article Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

B. Meissner, L. Rosenblatt, D. Trivedi, 2014 .

The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV

J. Romley, D. Goldman, T. Juday, 2016, Medical care research and review : MCRR.